Ajax Health has established a new medical technology company to develop a treatment for the most common heart rhythm disorder.

The new company, Cortex, has raised $90 million from KKR & Co. and Hellman & Friedman, according to a statement reviewed by Bloomberg News. Cortex is developing an integrated, comprehensive platform for evaluating and treating atrial fibrillation.